Τόμος 17 (2003) – Τεύχος 3 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 17 (2003) – Issue 3 – Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

 

 

Title The influence of the addition of melatonin to a magnesium ascorbyl phosphate-containing formulation on the mechanical properties of human skin
Authors Athanasia Varvaresou, Eleana Tsaoula and Efthimios Tsirivas

Department of Aesthetics and Cosmetology, The School of Health and Caring Professions, Technological Education Institution, Ag. Spyridonos Str., GR-12210-Egaleo, Athens, Greece

Citation Varvaresou, A., Tsaoula, E., Tsirivas, E.: The influence of the addition of melatonin to a magnesium ascorbyl phosphate-containing formulation on the mechanical properties of human skin, Epitheorese Klin. Farmakol. Farmakokinet. 17(3): 177-181 (2003)
Publication Date Received for publication: 20 September 2003

 Accepted for publication: 5 October 2003

Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Magnesium salt of ascorbyl-2-phosphate, melatonin, mechanical properties of human skin, cutometer.
Other Terms review article
Summary Certain vitamins and antioxidants have great popularity as primary ingredients in cosmetics. The magnesium salt of ascorbyl-2-phosphate (MAP) has been widely used as antioxidant and collagen promoting ingredient in cosmetic formulations. Melatonin (MELA) is known to be a potent antioxidant in vitro and in vivo. In this study we investigated the effect of the addition of melatonin to a MAP-containing formulation on the mechanical properties of human skin. A total of 10 healthy women aged 37-47 years, of phototype III and IV were studied. The MAP-MELA formulation was applied topically on the one side of the face twice daily for three weeks. The MAP formulation was applied on the other side of the face twice daily for the same period of time. The forehead was used as the untreated control area. Gross elasticity (Ua/Uf: 11.9%, p<0.05) and biological elasticity (Ur/Uf: 15.2%, p<0.005) were significantly improved for the MAP treated area. However topical application of MAP-MELA cream led to higher increase of these two elastic parameters (Ua/Uf: 16.7%, p<0.05) and (Ur/Uf: 23.7%, p<0.005). Regarding to viscoelastic to elastic ratio (Uv/Ue) a slightly higher increase was observed in the case of MAP-MELA treated site (11.4, p<0.005) in comparison with the MAP treated area (8.88 %, p<0.005).
References 1.    Lupo M.P.: Antioxidants and vitamins in cosmetics. Clin. Dermatol. 19: 467-473 (2001)

2.    Colven R.M., Pinell S.R.: Topical Vitamin C in ageing. Clin. Dermatol. 14: 227-234 (1996)

3.    Halpner A.D., Handlman G.J., Harris J.M., Belmont C.A. et al: Protection by vitamin C of loss of vitamin E in cultured rat hepatocytes. Arch. Biochem. Biophys. 359: 305-309 (1998)

4.    Phillips C.L., Combs S.B., Pinell S.R.: Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human fibroblasts. J. Invest. Dermatol. 130: 228-232 (1994)

5.    Geesin J.C., Gordon J.S., Berg R.A.: Regulation of collagen synthesis in human dermal fibroblasts by the sodium and magnesium salts of ascorbyl-2-phosphate: Skin Pharmacol 6: 65-71 (1993)

6.    Kobayashi S., Takehana M., Itoh S. Ogata E.: Protective effect of magnesium of magnesium-L-ascorbyl-2-phosphate against skin damage induced by UVB irradiation. Photochem. Photobiol. 64: 224-228 (1996)

7.    Antunes F., Barclay L.R.C., Ingold K.U., King M., Norris J.C., Scaiano J.C., Xi F.: On the antioxidant activity of melatonin. Free Rad. Biol. Med. 21: 307-315 (1996)

8.    Reiter R.J., Tan D.X., Osuna C., Gitto E.: Actions of melatonin in the reduction of oxidative stress. J. Biomed. Sci. 7: 444-458 (2000)

9.    Marshall K.A., Reiter R.J., Poeggeler B., Aruoma O.I., Halliwel B.: Evaluation of the antioxidant activity of melatonin in vitro. Free Rad. Biol. Med 26: 117-128 (1999)

10.  Livrea M.A., Tesoriere L., D ‘Arpa D., Morreale M.: Reaction of melatonin with lipoperoxy radicals in phos-pholipid bilayers. Free Rad. Biol. Med29. 706-711 (1997)

11.  Saija A., Tomaino A., Trombetta D., Pellegrino M., Tita B., Caruso A., Casteli F.: Interaction of melatonin with model membranes and possible implications in its photoprotective activity. E. J. Pharm. Biopharm. 53: 209-215 (2002)

12.  Bangha E., Eisner P., Kistler G.S.: Supression of UV-induced erythema by topical treatment with melatonin (N- acetyl-5-methoxytryptamine). A dose response study. Arch. Dermatol. Res. 288: 522-526 (1996)

13.  Lee B.J., Parrott K.A., Ayres J.W., Sack R.L.: Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res. Commun. Mol. Pathol. Pharmacol. 85: 337-346 (1994)

14.  Fischer T., Wigger-Alberti W., Elsner P.: Melatonin in der Dermatologie. Experimentelle und klinische Aspecte. Hautarzt 50: 5-11 (1999)

15.  Varvaresou A., Iakovou K., Filippatos E., Souli C., Calogeropouiou T., loannidou I., Kourounakis A., Pannecouque C., Witvrouw M., Padalko E., Neyts J., De Clercq E., Tsotinis A.: Synthesis, antiretroviral and antioxidant evaluation of a series of new benzo[b]furan derivatives. Arzneim. Forsch./Drug Res. 51: 156-162 (2001)

16.  lakovou K., Varvaresou A., Kourounakis A.P., Stead K., Sugden D., Tsotinis A.: Design, synthesis and biological evaluation of novel conformationally restrained melatoninergic analogs. J. Pharm. Pharmacol. 54: 147-156 (2002)

17.  Cua A.B., Wilhelm K.P., Maibach H.I.: Elastic properties of human skin: relation to age, sex and anatomical region Arch. Dermatol. Res. 282: 283-288 (1990)

18.  Dobrev H.: Use of cutometer to assess dermal oedema in erysipelas of the lower legs. Skin Res. Technol. 4: 155- 159 (1998)

19.  Dobrev H.: A study of human skin mechanical properties by means of cytometer. Folia Medica XLIV, 3: 5- 10 (2002)

20.  Bangha E., Lauth D., Kistler G.S.: Daytime serum levels of melatonin after topical application on the human skin. Skin Pharmacol. 10: 298-302 (1997)

21.  Poegeller B., Reiter R. J., Hardeland R. et al: Melatonin, a mediator of electron transfer and repair reactions, acts synergistically with the chain-breaking antioxidants ascorbate, trolox and glutathione. Neuroendocrinol. Lett. 17: 87-92 (1995)

22.  Dreher F., Gabard B., Schwindt D.A., Maibach H.: Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br. J. Dermatol. 139: 332-339 (1998)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2003– ANNUAL SUBSCRIPTION 2003
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

Bookmark the permalink.

Comments are closed.